# Long-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 Study

> **NCT02806011** · — · COMPLETED · sponsor: **Pharmicell Co., Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Alcoholic Liver Cirrhosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02806011
- **Lead sponsor:** Pharmicell Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2020-10
- **Final completion:** 2020-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02806011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02806011, "Long-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02806011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*